Actinium Pharmaceuticals
ATNM
#10526
Rank
S$43.31 M
Marketcap
S$1.38
Share price
2.86%
Change (1 day)
-37.19%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -S$32.7 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are S$0.09 Million. In 2025 the company made an earning of -S$46.34 Million, an increase over its 2024 earnings that were of -S$53.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$32.7 Million-29.43%
2025 -S$46.34 Million-13.95%
2024 -S$53.84 Million-18.87%
2023 -S$66.37 Million52.24%
2022 -S$43.6 Million36.61%
2021 -S$31.91 Million11.48%
2020 -S$28.63 Million1.46%
2019 -S$28.22 Million-7.37%
2018 -S$30.46 Million-11.46%
2017 -S$34.4 Million10.67%
2016 -S$31.09 Million15.7%
2015 -S$26.87 Million-14.86%
2014 -S$31.56 Million129.19%
2013 -S$13.77 Million-8.55%
2012 -S$15.06 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-S$47.54 Million 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA